| scholarly article | Q13442814 |
| P50 | author | Joseph Biederman | Q6281524 |
| Ronald C. Kessler | Q7364712 | ||
| Stephen Faraone | Q7609174 | ||
| Alan M Zaslavsky | Q88245848 | ||
| Laurence L Greenhill | Q109420186 | ||
| Kristina Secnik | Q125313313 | ||
| Keith Conners | Q33101434 | ||
| P2093 | author name string | Thomas Spencer | |
| T Bedirhan Ustün | |||
| Lenard A Adler | |||
| Savina Jaeger | |||
| Russell Barkley | |||
| P2860 | cites work | Adult psychiatric status of hyperactive boys grown up. | Q51995300 |
| Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. | Q52035084 | ||
| Retrospective reporting of childhood adversity: issues in assessing long-term recall. | Q52043403 | ||
| Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. | Q52163181 | ||
| Adolescent outcome of boys with attention-deficit/hyperactivity disorder and social disability: results from a 4-year longitudinal follow-up study. | Q52192458 | ||
| Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. | Q52204484 | ||
| Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. | Q52233283 | ||
| The adolescent outcome of hyperactive children: predictors of psychiatric, academic, social, and emotional adjustment. | Q52400241 | ||
| DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. | Q52881517 | ||
| A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. | Q52909713 | ||
| Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. | Q53678879 | ||
| A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. | Q55067290 | ||
| Assessing symptoms of attention deficit hyperactivity disorder in children and adults: Which is more valid? | Q57400499 | ||
| Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype | Q57400501 | ||
| Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments | Q61987754 | ||
| Alcohol abuse and attention deficit disorder | Q71104338 | ||
| Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study | Q71275880 | ||
| Predictive validity of categorically and dimensionally scored measures of disruptive childhood behaviors | Q72239350 | ||
| High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study | Q72565120 | ||
| Parent and child contributions to diagnosis of mental disorder: are both informants always necessary? | Q73268507 | ||
| Advancing age, declining ADHD | Q73671630 | ||
| The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder | Q74063773 | ||
| Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample | Q74370814 | ||
| Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome | Q74507735 | ||
| Young adult follow-up of hyperactive children: antisocial activities and drug use | Q76381177 | ||
| Measurement of three major subtypes of child neglect | Q80988775 | ||
| Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men | Q81111155 | ||
| Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association | Q28267877 | ||
| Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder | Q33798015 | ||
| Epidemiology of ADHD in school-age children | Q33914035 | ||
| Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample | Q33949984 | ||
| Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder | Q34005047 | ||
| Adults with ADHD. An overview | Q34312977 | ||
| Adult ADHD. Analysis of self-ratings on a behavior questionnaire. | Q34312990 | ||
| The National Comorbidity Survey Replication (NCS-R): background and aims. | Q34339246 | ||
| The US National Comorbidity Survey Replication (NCS-R): design and field procedures. | Q34339251 | ||
| The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. | Q34412660 | ||
| Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey | Q34439540 | ||
| Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview | Q34749777 | ||
| Attention deficit and hyperactivity disorder: review of genetic association studies. | Q35158718 | ||
| Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease | Q35583188 | ||
| Validity of adult retrospective reports of adverse childhood experiences: review of the evidence | Q35674920 | ||
| Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. | Q35738062 | ||
| Molecular genetics of attention-deficit/hyperactivity disorder | Q36159618 | ||
| The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) | Q39605659 | ||
| Continuous performance test performance in a normative epidemiological sample | Q40555805 | ||
| Psychopathology and early experience: a reappraisal of retrospective reports | Q40872147 | ||
| The overlap of attention deficit hyperactivity disorder with other common mental disorders | Q41466045 | ||
| Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder | Q43694059 | ||
| Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity | Q43708009 | ||
| Age-dependent decline of attention deficit hyperactivity disorder | Q44002029 | ||
| Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies | Q44290885 | ||
| The family history method using diagnostic criteria. Reliability and validity | Q44578310 | ||
| The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study | Q45107180 | ||
| Does stimulant treatment lead to substance use disorders? | Q47583355 | ||
| Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. | Q51942193 | ||
| Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. | Q51945507 | ||
| Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. | Q51952598 | ||
| Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. | Q51976307 | ||
| The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication | Q24632666 | ||
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | comorbidity | Q1414874 |
| attention deficit hyperactivity disorder | Q181923 | ||
| attention | Q6501338 | ||
| P304 | page(s) | 1442-1451 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication | |
| P478 | volume | 57 |
| Q37188220 | A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood |
| Q40272781 | A combined treatment approach for adults with ADHD--results of an open study of 43 patients |
| Q36984780 | A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study |
| Q45377205 | A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): improvements in executive functioning do not explain clinical improvement |
| Q36182701 | A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders |
| Q24632726 | A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD |
| Q33463879 | A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD) |
| Q33995154 | A review of the use of modafinil for attention-deficit hyperactivity disorder |
| Q34650130 | A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability |
| Q22252591 | ADD/ADHD and impaired executive function in clinical practice |
| Q47885270 | ADHD Symptomatology and Perceived Stress Among French College Students |
| Q47565893 | ADHD in acute care psychiatric inpatients |
| Q45305754 | ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients |
| Q92736860 | ADHD remission, inclusive special education, and socioeconomic disparities |
| Q47586798 | ADHD symptoms in healthy adults are associated with stressful life events and negative memory bias |
| Q39142770 | Academic Achievement in Adults with a History of Childhood Attention-Deficit/Hyperactivity Disorder: A Population-Based Prospective Study |
| Q37815474 | Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder |
| Q38205020 | Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults |
| Q36876248 | Adolescent and caregiver reports of ADHD symptoms among inner-city youth: agreement, perceived need for treatment, and behavioral correlates |
| Q38810032 | Adult ADHD Symptomatology in Active Duty Army Personnel: Results From the Army Study to Assess Risk and Resilience in Servicemembers. |
| Q37224553 | Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD |
| Q33984093 | Adult attention deficit hyperactivity disorder is associated with asthma. |
| Q35577398 | Adult attention deficit hyperactivity disorder is associated with migraine headaches |
| Q33680015 | Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions |
| Q48420522 | Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications |
| Q43213069 | Alcohol use and physical health in adolescence: a general population survey of 8,983 young people in North-Trøndelag, Norway (the Young-HUNT study). |
| Q36982133 | Anxiety disorders and drug dependence: evidence on sequence and specificity among adults |
| Q51924724 | Assessing the concordance of measures used to diagnose adult ADHD. |
| Q37108181 | Assessing the efficacy of treatments for ADHD : overview of methodological issues |
| Q37623848 | Assessment and monitoring of treatment response in adult ADHD patients: current perspectives |
| Q37607911 | Assessment of adult attention-deficit/hyperactivity disorder |
| Q44495387 | Association between craving and attention deficit/hyperactivity disorder symptoms among patients with alcohol use disorders |
| Q48842106 | Association between obesity and adult attention-deficit/hyperactivity disorder in a German community-based sample |
| Q39223758 | Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population. |
| Q37200559 | Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder |
| Q36992386 | Associations between attention deficit hyperactivity disorder symptom domains and DSM-IV lifetime substance dependence |
| Q37348940 | Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized Trials |
| Q28267079 | Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients |
| Q34407427 | Attention Deficit/Hyperactivity Disorder: A Focused Overview for Children’s Environmental Health Researchers |
| Q46824390 | Attention deficit disorder: not just for children |
| Q37596910 | Attention deficit hyperactivity disorder and athletes |
| Q34448231 | Attention deficit hyperactivity disorder in Australian adults: prevalence, persistence, conduct problems and disadvantage |
| Q92897449 | Attention-Deficit Hyperactivity Disorder Across the Lifespan |
| Q35810578 | Attention-Deficit/Hyperactivity Disorder, Autistic Traits, and Substance Use Among Missouri Adolescents |
| Q91318414 | Attention-deficit hyperactivity disorder (ADHD) in adults attending addiction treatment in Ireland: preliminary international ADHD in substance-use disorders prevalence study (IASP) results |
| Q39916663 | Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy |
| Q28284641 | Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature |
| Q80268744 | Attention-deficit/hyperactivity disorder (ADHD) in the course of life |
| Q43915679 | Attention-deficit/hyperactivity disorder comorbidity in a sample of veterans with posttraumatic stress disorder. |
| Q48291155 | Attention-deficit/hyperactivity disorder in a prebariatric surgery sample |
| Q35125265 | Attention-deficit/hyperactivity disorder in childhood is associated with cognitive test profiles in the geriatric population but not with mild cognitive impairment or Alzheimer's disease |
| Q37033964 | Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment |
| Q39056793 | Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy |
| Q36858837 | Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine |
| Q30485511 | Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype |
| Q28284031 | Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial |
| Q58408125 | Candidate system analysis in ADHD: Evaluation of nine genes involved in dopaminergic neurotransmission identifies association withDRD1 |
| Q35761766 | Cannabis use and other predictors of the onset of daily cigarette use in young men: what matters most? Results from a longitudinal study |
| Q35089391 | Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder |
| Q48345944 | Characteristics of ADHD among Omani schoolchildren using DSM-IV: descriptive study |
| Q45070504 | Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use. |
| Q36717211 | Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study |
| Q94502574 | Childhood Adversity and Dimensional Variations in Adult Sustained Attention |
| Q33663243 | Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. |
| Q37087432 | Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study |
| Q39702502 | Children referred for evaluation for ADHD: comorbidity profiles and characteristics associated with a positive diagnosis. |
| Q37798257 | Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder |
| Q43453720 | Clinical correlates of oppositional defiant disorder and attention-deficit/hyperactivity disorder in adults |
| Q47970819 | Clinical, Sociobiological, and Cognitive Predictors of ADHD Persistence in Children Followed Prospectively Over Time |
| Q36677656 | Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children |
| Q34677924 | Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study |
| Q37505871 | Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective |
| Q37703900 | Comorbidity of Adult Attention Deficit and Hyperactivity Disorder in Bipolar Patients: Prevalence, Sociodemographic and Clinical Correlates |
| Q47184759 | Comorbidity of Internet use disorder and attention deficit hyperactivity disorder: Two adult case-control studies. |
| Q51704940 | Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. |
| Q44498724 | Comorbidity of asthma with ADHD. |
| Q44985957 | Comorbidity of migraine with ADHD. |
| Q48894972 | Comparing Methods to Determine Persistence of Childhood ADHD Into Adulthood: A Prospective, Population-Based Study. |
| Q36867824 | Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders |
| Q48402451 | Cortical Thickness in Young Treatment-Naive Children With ADHD. |
| Q35106967 | Cross-fostering differentially affects ADHD-related behaviors in spontaneously hypertensive rats |
| Q37314533 | Current issues around the pharmacotherapy of ADHD in children and adults |
| Q36960203 | Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder |
| Q47580271 | DSM-5 and Other Symptom Thresholds for ADHD: Which Is the Best Predictor of Impairment in College Students? |
| Q34708568 | Developmental Exposure to Polybrominated Diphenyl Ethers and Neurodevelopment |
| Q33504394 | Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD). |
| Q38055292 | Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorder |
| Q48872262 | Distinguishing symptoms of ADHD from other psychiatric disorders in the adult primary care setting |
| Q35184452 | Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? |
| Q43147848 | Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? |
| Q35761836 | Does comorbid depression predict subsequent adverse life events in youth with attention-deficit/hyperactivity disorders? |
| Q50440522 | Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder |
| Q55024601 | ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial. |
| Q92635015 | Early Attentional Modulation by Working Memory Training in Young Adult ADHD Patients during a Risky Decision-Making Task |
| Q45969926 | Effectiveness of a program using a vehicle tracking system, incentives, and disincentives to reduce the speeding behavior of drivers with ADHD. |
| Q35024455 | Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. |
| Q33810786 | Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood |
| Q52657206 | Event-Related Potentials during a Gambling Task in Young Adults with Attention-Deficit/Hyperactivity Disorder. |
| Q46949050 | Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. |
| Q39620251 | Factor structure of a sluggish cognitive tempo scale in clinically-referred children |
| Q51335077 | Factors contributing to the utilization of adult mental health services in children and adolescents diagnosed with hyperkinetic disorder. |
| Q51862820 | Fading memories: retrospective recall inaccuracies in ADHD. |
| Q38414210 | Feasibility of Attachment Based Family Therapy for depressed clinic-referred Norwegian adolescents |
| Q48082237 | Footedness Is Associated With ADHD Symptoms in the Adult General Population |
| Q81039063 | From childhood into adulthood: the changing face of ADHD |
| Q46925492 | Functional outcomes in the treatment of adults with ADHD. |
| Q34257043 | Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder |
| Q28254567 | Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder |
| Q90264698 | Habit Expression and Disruption as a Function of Attention-Deficit/Hyperactivity Disorder Symptomology |
| Q58408091 | Haplotype co-segregation with attention deficit-hyperactivity disorder in unrelated german multi-generation families |
| Q33944593 | Health state utilities associated with adult attention-deficit/hyperactivity disorder |
| Q46469903 | How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample |
| Q33639427 | How do trait dimensions map onto ADHD symptom domains? |
| Q48257339 | Inattention and hyperactivity-impulsivity: psychobiological and evolutionary underpinnings of ADHD. |
| Q36607357 | Innovations and recent trends in the treatment of ADHD. |
| Q38267796 | Inpatient physicians and nurses with dual diagnosis: an exploratory study |
| Q48709038 | Interaction of adrenocortical activity and autonomic arousal on children's externalizing and internalizing behavior problems |
| Q34477320 | Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study |
| Q50780419 | Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. |
| Q60643399 | Large-scale brain functional network topology disruptions underlie symptom heterogeneity in children with attention-deficit/hyperactivity disorder |
| Q51902173 | Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication. |
| Q33865315 | Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder |
| Q38592540 | Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study. |
| Q36098336 | Long-term consequences of childhood ADHD on criminal activities. |
| Q36591843 | Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD). |
| Q80558994 | Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care |
| Q43724194 | Memory tests in subgroups of adult attention deficit hyperactivity disorder reveals simultaneous capacity deficit. |
| Q41383208 | Mental Health Problems Among Preschoolers in Germany: Results of the BELLA Preschool Study |
| Q34092586 | Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD). |
| Q34172165 | Methylphenidate off-label use and safety |
| Q37040133 | Mindfulness-Based Cognitive Therapy and the Adult ADHD Brain: A Neuropsychotherapeutic Perspective |
| Q40180283 | Misuse of Methylphenidate |
| Q37290084 | Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study |
| Q50301649 | Motor and gestural performance in children with autism spectrum disorders, developmental coordination disorder, and/or attention deficit hyperactivity disorder |
| Q34661589 | Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. |
| Q47118573 | Multiple Intelligences Profiles of Children with Attention Deficit and Hyperactivity Disorder in Comparison with Nonattention Deficit and Hyperactivity Disorder |
| Q50555192 | Naming Speed of Adolescents and Young Adults with Attention Deficit Hyperactivity Disorder: Differences in Alphanumeric Versus Color/Object Naming. |
| Q47551192 | National Patterns of Commonly Prescribed Psychotropic Medications to Young People |
| Q48410237 | Neural correlates (ERP/fMRI) of voluntary selection in adult ADHD patients |
| Q48212126 | Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naïve adults with attention-deficit/hyperactivity disorder |
| Q50802416 | Neuropsychological weaknesses in adult ADHD; cognitive functions as core deficit and roles of them in persistence to adulthood. |
| Q21203530 | Nosologomania: DSM & Karl Jaspers' critique of Kraepelin |
| Q51870475 | Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. |
| Q64029403 | On the relation of mind wandering and ADHD symptomatology |
| Q35421270 | Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery |
| Q34992295 | Our current understanding of adult ADHD |
| Q40120600 | Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD. |
| Q90687201 | Patients with mutations of the Thyroid hormone beta-receptor show an ADHD-like phenotype for performance monitoring: an electrophysiological study |
| Q40961281 | Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. |
| Q48364841 | Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study. |
| Q34502493 | Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. |
| Q34587419 | Predictors of onset of cannabis and other drug use in male young adults: results from a longitudinal study |
| Q30244067 | Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis |
| Q34554897 | Preferences related to attention-deficit/hyperactivity disorder and its treatment |
| Q47661909 | Prevalence of sexual dysfunctions and other sexual disorders in adults with attention-deficit/hyperactivity disorder compared to the general population |
| Q35902257 | Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication |
| Q54954898 | Probe-caught spontaneous and deliberate mind wandering in relation to self-reported inattentive, hyperactive and impulsive traits in adults. |
| Q50077441 | Prospective memory in children with attention deficit hyperactivity disorder: a review |
| Q33800284 | Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder |
| Q39216392 | Psychiatric Comorbidities in a New Zealand Sample of Adults With ADHD. |
| Q43180467 | Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder |
| Q34752133 | Psychometric properties of the Chinese version of the adult ADHD Self-report Scale. |
| Q36594949 | Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). |
| Q24605530 | Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes |
| Q31108345 | Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units |
| Q37308847 | Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder |
| Q37612683 | Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management |
| Q51341181 | Relationship between attention-deficit/hyperactivity disorder and trans fatty acids intake in female adolescents. |
| Q37448826 | Relationship of ferritin to symptom ratings children with attention deficit hyperactivity disorder: effect of comorbidity |
| Q53176187 | Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). |
| Q22251206 | Review of Pediatric Attention Deficit/Hyperactivity Disorder for the General Psychiatrist |
| Q92994543 | Revisiting ADHD age-of-onset in adults: to what extent should we rely on the recall of childhood symptoms? |
| Q37686428 | Risk and protective factors for mental health problems in preschool-aged children: cross-sectional results of the BELLA preschool study |
| Q46162576 | Role of COMT in ADHD: a systematic meta-analysis |
| Q37354631 | Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder |
| Q51871899 | Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates. |
| Q48521793 | Screening of adult ADHD among patients presenting for bariatric surgery |
| Q91830503 | Shared genetic background between children and adults with attention deficit/hyperactivity disorder |
| Q38782900 | Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research |
| Q37021354 | Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future |
| Q41529678 | Stimulant Treatment of Young People in the United States |
| Q35092195 | Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale |
| Q55007123 | Temperament in Adulthood Attention Deficit-Hyperactivity Disorder without Bipolar Disorder. |
| Q43992342 | Test–Retest Reliability of Two Patient-Report Measures for Use in Adults With ADHD |
| Q37675727 | The Adult ADHD Self-Report Scale (ASRS): utility in college students with attention-deficit/hyperactivity disorder |
| Q50655015 | The Impact of DSM-5 A-Criteria Changes on Parent Ratings of ADHD in Adolescents. |
| Q64990554 | The Longitudinal Relation between Observed Maternal Parenting in the Preschool Period and the Occurrence of Child ADHD Symptoms in Middle Childhood. |
| Q22241206 | The Potential for Misuse and Abuse of Medications in ADHD: A Review |
| Q36465741 | The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample |
| Q26849765 | The association of ADHD symptoms to self-harm behaviours: a systematic PRISMA review |
| Q64029391 | The devil is in the detail: exploring the intrinsic neural mechanisms that link attention-deficit/hyperactivity disorder symptomatology to ongoing cognition |
| Q39792295 | The effects of attention-deficit/hyperactivity disorder on employment and household income. |
| Q45978294 | The estimated prevalence and correlates of adult ADHD in a German community sample. |
| Q83431392 | The evidence-based pharmacological treatment of paediatric ADHD |
| Q34452756 | The impact of ADHD symptoms and global impairment in childhood on working disability in mid-adulthood: a 28-year follow-up study using official disability pension records in a high-risk in-patient population |
| Q33865138 | The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns |
| Q36955159 | The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome |
| Q38023225 | The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents |
| Q27002629 | The neurobiological link between OCD and ADHD |
| Q22252222 | The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): What every clinician should know |
| Q39084636 | The predictors of persistent DSM-IV disorders in 3-year follow-ups of the British Child and Adolescent Mental Health Surveys 1999 and 2004. |
| Q36100175 | The quality of life of adults with attention deficit hyperactivity disorder: a systematic review |
| Q46112260 | The relationship between grey-matter and ASD and ADHD traits in typical adults |
| Q37975550 | The use of lisdexamfetamine dimesylate for the treatment of ADHD. |
| Q38140019 | The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. |
| Q34673021 | The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder. |
| Q37183477 | Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder |
| Q46655617 | Tracking Distraction |
| Q47710123 | Trajectories of attention-deficit/hyperactivity disorder dimensions in adults |
| Q35600580 | Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations |
| Q33736227 | Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study |
| Q92898347 | Treatment for Substance Use Disorder With Co-Occurring Mental Illness |
| Q36799361 | Treatment strategies for co-occurring ADHD and substance use disorders |
| Q37682858 | Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan |
| Q50787579 | Validating a self-report screen for ADHD in early adulthood using childhood parent and teacher ratings. |
| Q41687324 | Validity and Reliability of Adult ADHD Self-Report Scale Thai Version (ASRS-V1.1 TH). |
| Q34049049 | Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria |
| Q44778054 | Visual memory as a potential cognitive endophenotype of attention deficit hyperactivity disorder. |
| Q37572604 | When diagnosing ADHD in young adults emphasize informant reports, DSM items, and impairment. |
| Q57243211 | Young adult mental health and functional outcomes among individuals with remitted, persistent and late-onset ADHD |
| Q86076161 | [ADHD in adulthood: Diagnostics and therapy] |
| Q89146139 | [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics] |
| Q51932155 | [Neuro-enhancement from an addiction specialist's viewpoint]. |
Search more.